top of page

Join us at RSNA

December 1-5

Booth #7361

Market Opportunity

New York Hospitals

237

London Hospitals

84

Large Target Addressable Markets​

Long Term: Build out on the long tail of stroke

  • Through partnerships with leading strategic medical hospitals eg Imperial College Healthcare NHS Trust, London; NYU Langone and Mt Sinai, NYC - to penetrate other surgical specialties

  • Achieve rapid scale through expansion to their downstream feeder hospitals

Initial focus on interventional neuroradiologists

  • Interventionists are technical buyers with established user communities

  • Eager to try technology that can make their demanding procedures easier

  • Firmly establishes Medical iSight’s credentials for improving apex of difficulty procedures

$5.8bn

Neuro

$29bn

Cardio

$58bn

Gastro

MiS Milestones

  • MiS Founded

2019

  • V1 prototype deployed for COVID ward rounds at St Mary’s Hospital, London

  • Professor Kyriakos Lobotesis joins as Clinical co-founder

2020

  • V1 UKCA Mark registered as Class 1 Medical Device

  • Awarded 2 UK Government grants totalling £500,000

  • Agreement with St George’s Hospital for V1 software to be used for Diep Flap reconstructive surgery

  • Paper Published by Martin, Kinross, Pratt on AR use during COVID

2021

  • Award winning BBC 2 documentary "Your Body Uncovered” featuring V1 software

  • 4 specialty collaboration signed with NYU Langone Hospital, NY

  • 1st Procedure, Breast Reconstruction Imperial NHS Trust, London 

  • SAFE and Series A1 closes raising $2.5m

  • Ethics Approval: Oncoplastics Imperial NHS Trust, London

2022

  • 2 patents filed in UK

  • Vice-Admiral Rocky Bono joins as Chief of Surgical Innovation

  • MHRA approval for first in-human neuro trial using AR

  • Agreement signed with Charing Cross Hospital for 50 patient  trial to commence

  • Revenue deal agreed with private screening clinic for visualisation software

  • Ethics Approval achieved: Neuro Imperial NHS Trust, London

  • First Revenue at St George’s University Hospital, London

  • Ethics Approval: GI Imperial NHS Trust, London

  • Awarded £1.3m NIHR Government grant

2023

  • Feasibility Trial Feedback

  • Mount Sinai Collaboration

  • NVIDIA Partnership

  • NYU Langone partnership - Neuro progress

  • Progress and prepare FDA strategy and submission

  • Conference speaker slots

2024 Goals

Investor Presentation

If you are interested in investing, please get in touch to receive further investor information:

​

investor@medicalisight.com

bottom of page